Acceptance & Commitment Therapy for Psychotic Inpatients

May 4, 2018 updated by: Uppsala University

The overarching aim of the research project is to investigate whether Acceptance & Commitment Therapy (ACT) is an efficacious psychotherapeutic method of treatment for inpatients suffering from acute psychosis.

The method will be applied in two ways. Firstly, as an individual treatment for patients. Secondly, as an integrated part of the daily work on an inpatient ward, administered by nurses and assistant nurses trained in the method.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
      • Västerås, Sweden
        • Västmanland Hospital, Västerås, Västmanland County Council

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admitted to a specified psychiatric inpatient ward during the time-period of the study; psychotic spectrum diagnosis as specified in patient charts; assessed by contact person on the ward as having delusions or hallucinations.

Exclusion Criteria:

  • Cognitive difficulties to an extent where informed consent cannot be given.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acceptance & Commitment Therapy
A variant of cognitive behavior therapy focused on acceptance and valued living in the presence of distressing symptoms.
Behavioral: Acceptance & Commitment Therapy
A variant of cognitive behavior therapy focused on acceptance and valued living in the presence of distressing symptoms.
Active Comparator: Attention
Supportive conversation at a frequency and length corresponding to the experimental condition.
Behavioral: Attention
Supportive conversation at a frequency and length corresponding to the experimental condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rehospitalization
Time Frame: 12 months
Whether or not, and if so for how many days, a patient has ben readmitted to inpatient care during the follow-up period.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bull's Eye Values Inventory
Time Frame: 12 months
Quality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
12 months
EQ-5D
Time Frame: 12 months
Health related quality of life instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
12 months
Clinical Global Impression Scale
Time Frame: 12 months
Symptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
12 months
Acceptance & Action Questionnaire
Time Frame: 12 months
Psychological flexibility instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
12 months
Psychotic Symptom Rating Scales
Time Frame: 12 months
Symptom severity instrument to be administered before treatment, after treatment, and at 3, 6 and 12 month follow-up.
12 months
Checklist of Unit Behaviors
Time Frame: During inpatient care.
Measure for degree of activity on the ward.
During inpatient care.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uppsala University

Collaborators

Stockholm University

Investigators

  • Study Director: Tobias Lundgren, PhD, Stockholm University; Karolinska Institutet, department of Clinical Neuroscience & Centre for Psychiatry Research and Education, Stockholm County Council

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

December 1, 2017

Study Completion (Actual)

December 1, 2017

Study Registration Dates

First Submitted

May 27, 2015

First Submitted That Met QC Criteria

May 28, 2015

First Posted (Estimate)

May 29, 2015

Study Record Updates

Last Update Posted (Actual)

May 11, 2018

Last Update Submitted That Met QC Criteria

May 4, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2014/541

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Psychosis

Clinical Trials on Acceptance & Commitment Therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe